Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Lancet (London, England)|April 18, 2015
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trialPeter Hillmen, Tadeusz Robak, Ann Janssens, et al.
Blood|March 6, 2012
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter studyMyron S Czuczman, Luis Fayad, Vincent Delwail, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
Blood|August 18, 2016
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myelomaTorben Plesner, Hendrik-Tobias Arkenau, Peter Gimsing, et al.
The New England Journal of Medicine|August 27, 2015
Targeting CD38 with Daratumumab Monotherapy in Multiple MyelomaHenk M Lokhorst, Torben Plesner, Jacob P Laubach, et al.
The New England Journal of Medicine|October 6, 2016
Daratumumab, Lenalidomide, and Dexamethasone for Multiple MyelomaMeletios A Dimopoulos, Albert Oriol, Hareth Nahi, et al.
Lancet (London, England)|January 19, 2016
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trialSagar Lonial, Brendan M Weiss, Saad Z Usmani, et al.
Pageof 3